Postprocedural Anticoagulation After LAAO: Comparing DOACs, Warfarin, and Individual DOAC Agents
Circ Arrhythm Electrophysiol
.
2026 Mar;19(3):e014599.
doi: 10.1161/CIRCEP.125.014599.
Epub 2026 Feb 24.
Authors
Yong Hao Yeo
1
,
Hermon Kha Kin Wong
2
,
Aravinthan Vignarajah
3
,
Min Choon Tan
4
,
Ramzi Ibrahim
4
,
Nishanthi Vigneswaramoorthy
5
,
Hicham El-Masry
4
,
Justin Z Lee
6
,
Dan Sorajja
4
Affiliations
1
Department of Internal Medicine/Pediatrics, Corewell Health William Beaumont University Hospital, Royal Oak, MI (Y.H.Y.).
2
Department of Medicine, University of Malaysia Sabah, Malaysia (H.K.K.W.).
3
Department of Internal Medicine, Cleveland Clinic Fairview Hospital, OH (A.V.).
4
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ (M.C.T., R.I., H.E.-M., D.S.).
5
Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY (N.V.).
6
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, OH (J.Z.L.).
PMID:
41732864
DOI:
10.1161/CIRCEP.125.014599
No abstract available
Keywords:
anticoagulants; hemorrhage; risk factors; warfarin.
Publication types
Letter